Dr. Erwei Song and Dr. Hai Hu are both Professors at Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

• Chap. 1 The Dawning of Translational Breast Cancer: from Bench to Bedside.- Chap. 2 Biomarker Studies in Early Detection and Prognosis of Breast Cancer.- Chap. 3 The Preventive Intervention of Hereditary Breast Cancer.- Chap. 4 Predicting and Overcoming Chemotherapeutic Resistance for Breast Cancer.- Chap. 5 Studies on DNA Damage Repair and Precision Radiotherapy for Breast Cancer.- Chap. 6 Targeted Therapies against Growth Factor Signaling in Breast Cancer.- Chap. 7 Targeting Stemness: Implications for Precision Medicine in Breast Cancer.- Chap. 8 Disrupting Tumor Angiogenesis and “the Hunger Games” for Breast Cancer.- Chap. 9 Key Factors in Breast Cancer Dissemination and Establishment at the Bone: Past, Present and Future Perspectives.- Chap. 10 Perspectives of Reprogramming Breast Cancer Metabolism.- Chap. 11 Metabolic Changes during Cancer Cachexia Pathogenesis.- Chap. 12 Cell Cycle Regulation in Treatment of Breast Cancer .- Chap. 13 BRCA Gene Mutations and Poly (ADP-ribose) Polymerase Inhibitors in Triple-negative Breast Cancer.- Chap. 14 Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.- Chap. 15 Progress in Vaccine Therapies for Breast Cancer.- Chap. 16 Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.- Chap 17 New Approaches in CAR-T Cell Immunotherapy for Breast Cancer.- Chap 18 Immune Checkpoint Blockade in Breast Cancer Therapy.

Dr. Erwei Song and Dr. Hai Hu are both Professors at Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

• Chap. 1 The Dawning of Translational Breast Cancer: from Bench to Bedside.- Chap. 2 Biomarker Studies in Early Detection and Prognosis of Breast Cancer.- Chap. 3 The Preventive Intervention of Hereditary Breast Cancer.- Chap. 4 Predicting and Overcoming Chemotherapeutic Resistance for Breast Cancer.- Chap. 5 Studies on DNA Damage Repair and Precision Radiotherapy for Breast Cancer.- Chap. 6 Targeted Therapies against Growth Factor Signaling in Breast Cancer.- Chap. 7 Targeting Stemness: Implications for Precision Medicine in Breast Cancer.- Chap. 8 Disrupting Tumor Angiogenesis and “the Hunger Games” for Breast Cancer.- Chap. 9 Key Factors in Breast Cancer Dissemination and Establishment at the Bone: Past, Present and Future Perspectives.- Chap. 10 Perspectives of Reprogramming Breast Cancer Metabolism.- Chap. 11 Metabolic Changes during Cancer Cachexia Pathogenesis.- Chap. 12 Cell Cycle Regulation in Treatment of Breast Cancer .- Chap. 13 BRCA Gene Mutations and Poly (ADP-ribose) Polymerase Inhibitors in Triple-negative Breast Cancer.- Chap. 14 Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.- Chap. 15 Progress in Vaccine Therapies for Breast Cancer.- Chap. 16 Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.- Chap 17 New Approaches in CAR-T Cell Immunotherapy for Breast Cancer.- Chap 18 Immune Checkpoint Blockade in Breast Cancer Therapy.

Dr. Erwei Song and Dr. Hai Hu are both Professors at Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

• Chap. 1 The Dawning of Translational Breast Cancer: from Bench to Bedside.- Chap. 2 Biomarker Studies in Early Detection and Prognosis of Breast Cancer.- Chap. 3 The Preventive Intervention of Hereditary Breast Cancer.- Chap. 4 Predicting and Overcoming Chemotherapeutic Resistance for Breast Cancer.- Chap. 5 Studies on DNA Damage Repair and Precision Radiotherapy for Breast Cancer.- Chap. 6 Targeted Therapies against Growth Factor Signaling in Breast Cancer.- Chap. 7 Targeting Stemness: Implications for Precision Medicine in Breast Cancer.- Chap. 8 Disrupting Tumor Angiogenesis and “the Hunger Games” for Breast Cancer.- Chap. 9 Key Factors in Breast Cancer Dissemination and Establishment at the Bone: Past, Present and Future Perspectives.- Chap. 10 Perspectives of Reprogramming Breast Cancer Metabolism.- Chap. 11 Metabolic Changes during Cancer Cachexia Pathogenesis.- Chap. 12 Cell Cycle Regulation in Treatment of Breast Cancer .- Chap. 13 BRCA Gene Mutations and Poly (ADP-ribose) Polymerase Inhibitors in Triple-negative Breast Cancer.- Chap. 14 Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.- Chap. 15 Progress in Vaccine Therapies for Breast Cancer.- Chap. 16 Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.- Chap 17 New Approaches in CAR-T Cell Immunotherapy for Breast Cancer.- Chap 18 Immune Checkpoint Blockade in Breast Cancer Therapy.